Get the Stockscreener App
3.2699
0.20%
-0.0064
After Hours:
3.27
0.0001
+0.00%
Amplify Seymour Cannabis Etf stock is traded at $3.2699, with a volume of 35,685.
It is down -0.20% in the last 24 hours and down -31.39% over the past month.
See More
Previous Close:
$3.2763
Open:
$3.26
24h Volume:
35,685
Relative Volume:
1.12
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.68%
1M Performance:
-31.39%
6M Performance:
-37.72%
1Y Performance:
-20.83%
1-Day Range:
$3.23
$3.3092
1-Week Range:
$3.20
$3.47
52-Week Range:
$3.01
$6.48
Amplify Seymour Cannabis Etf Stock (CNBS) Company Profile
Name
Amplify Seymour Cannabis Etf
Sector
Industry
Phone
-
Address
-
Compare CNBS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CNBS | 3.2699 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Amplify Seymour Cannabis Etf Stock (CNBS) Latest News
Marijuana rescheduling unlikely to lead to cannabis banking reform - MSN
Weed stocks spike after report on Trump support for marijuana reforms - MSN
6 Best-Performing Marijuana ETFs for November 2024 - NerdWallet
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - MSN
Cannabis stocks rebound amid DEA rescheduling review - MSN
EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say - Benzinga
Victory In Commerce Clause Case Could Be The Silver Bullet For Cannabis Industry, Experts Say - Benzinga
7 Best Marijuana ETFs to Consider in 2024 - The Motley Fool
122,438 Shares in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) Bought by Gateway Wealth Partners LLC - Defense World
Wealth Alliance Makes New Investment in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed By Invezz - Investing.com Canada
Marijuana ETFs: The Pros and Cons - Investopedia
Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy Growth - The Motley Fool
CNBC’s Tim Seymour takes ‘glass half full’ view of second quarter cannabis earnings - Green Market Report
Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic - Seeking Alpha
5 Best Cannabis ETFs to Invest In - Securities.io
Amplify Seymour Cannabis ETF (CNBS-A) QuotePress Release - The Globe and Mail
How to invest in cannabis stocks - CNN Underscored
Cannabis Investing In The Age Of Legalization - Seeking Alpha
Cannabis ETFs are off to a strong September. Will the buzz last? - MSN
Cannabis is a $200B market cap industry, analyst says at SA Investing Summit - MSN
Cannabis is a $200B market cap: Pablo Zuanic (NYSEARCA:MSOS) - Seeking Alpha
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth - Markets Insider
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth' - Markets Insider
6 Best-Performing Marijuana ETFs for June 2024 - NerdWallet
Could Rescheduling Finally Bring Institutional Investment in to Cannabis? - Business of Cannabis -
Cannabis rally sparks concerns amid moves to mainstream - MSN
How the (CNBS) price action is used to our Advantage - Stock Traders Daily
7 Best Marijuana ETFs to Buy in 2024 - U.S News & World Report Money
Best ETF Areas of Last Week - Yahoo Finance
Marijuana ETF Space Gets Packed - Yahoo Movies Canada
Cannabis ETFs Soar On Reports DEA Plans To Reclassify Marijuana - Forbes
Marijuana stocks rise on cannabis rescheduling (NYSEARCA:MSOS) - Seeking Alpha
Cannabis stocks gain as DEA pressed for marijuana rescheduling - Seeking Alpha
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds - Benzinga
Is Rescheduling a Certainty for Cannabis? ETFs That Surge - Yahoo Finance
Cannabis ETFs Jump on Imminent Rescheduling News - Yahoo Finance
Understanding Cannabis ETFs’ Wacky Divergence - ETF Trends
Cannabis stocks rebound amid DEA's rescheduling review - Seeking Alpha
Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks - Benzinga
Marijuana ETFs Rise – and Fall – on Regulatory Hopes - ETF Trends
Cannabis Stocks & ETFs: Can the Recent Surge Continue? - Yahoo Lifestyle Australia
Top Performing ETFs: Cannabis ETFs Lead - Nasdaq
MJ: The Long Awaited Breakout For Marijuana Stocks Is Here! - TheStreet
Amplify's Christian Magoon on Purchase of ETFMG's ETFs - ETF Trends
Here’s Why These Cannabis ETFs Aren’t Very Good - New Cannabis Ventures
'The Only Thing We Can Do As An Industry Is Learn,' Says Emily Paxhia On Navigating The Cannabis Investment Landscape - Benzinga
VA And DoD Face Criticism From Rep. Blumenauer Over 'Misguided' Denial Of PTSD Treatment With Medical Can - Benzinga
Worst Performing ETFs of the Year - etf.com
How to Buy Marijuana Stocks: A Beginner's Guide - Money
Amplify Seymour Cannabis Etf Stock (CNBS) Financials Data
There is no financial data for Amplify Seymour Cannabis Etf (CNBS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):